Pfizer launches trial data sharing service
September 23, 2013Medical Communications, Sales and Marketing Pfizer, blue button
Pfizer has launched a first-of-its-kind project that enables patients who have participated in clinical trials the ability to download their …
GSK/Prosensa confirm orphan drug setback
September 23, 2013Sales and Marketing GSK, MD, Prosensa, drisapersen
An experimental treatment by GSK and Prosensa for a rare type of muscle-degenerating disease has failed to meet its primary …
Strengthening the pharma supply chain
September 23, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
Last year’s discovery of fake versions of Roche’s cancer drug Avastin in the US supply chain served as a stark …
Perrigo appoints FDA director as regulatory head
September 23, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing perrigo. fda, webber
OTC healthcare products firm Perrigo Company has appointed the FDA’s Keith Webber to be its head of Regulatory Review. The …
FDA spends big on social media outlook
September 20, 2013Medical Communications, Sales and Marketing FDA, Facebook, PMCPA, Psoriasis 360, Twitter
Teva in Cancer Research UK tie-up
September 20, 2013Medical Communications, Research and Development, Sales and Marketing CRUK, Cancer, R&D, Teva
Google launches new health business
September 19, 2013Medical Communications, Sales and Marketing Apple, Genentech, Levinson, Roche, google
Novartis launches China investigation
September 18, 2013Medical Communications, Sales and Marketing Alcon, China, Novartis, corrpution
NICE: we need more Aubagio data
September 18, 2013Sales and Marketing Aubagio, Genzyme, MS, NICE, Sanofi
Sanofi’s Lemtrada given European go ahead
September 18, 2013Research and Development, Sales and Marketing Aubagio, Lemtrada, MS, Sanofi, gilenya
Latest content
Report highlights scope to expand day surgery
September 23, 2026
Sygnature formalises drug discovery collaboration with X-Chem
September 22, 2026
Codis appoints Steven Facer as chief commercial officer
September 21, 2026
Danish medical cannabis use rises as regulator reports no new safety signals
September 21, 2026
